American Society of Clinical Oncology

SHERPA: White

People

  1. Fleisher
    Fleisher
  2. Hamlin
    Hamlin
  3. Horwitz
    Horwitz
  4. Sarasohn
    Sarasohn
  5. Seshan
    Seshan
  6. Sirotnak
    Sirotnak
  7. Zelenetz
    Zelenetz

Groups

  1. Biostatistics Service (1)
  2. Body Imaging Service (1)
  3. Center for Hematologic Malignancies (1)
  4. Center for Pancreatic Cancer Research (1)
  5. Department of Medicine (1)
  6. Epidemiology and Biostatistics (1)
  7. Hematologic Malignancies, Division of (1)
  8. Lymphoma (1)
  9. Population Sciences Research Program (1)
  10. Radiology, Department of (1)
Search Within
  1. "Martin Fleisher"
  2. "Craig Moskowitz"
Formats
  1. Journal Article (1)
Groups
  1. Biostatistics Service (1)
  2. Body Imaging Service (1)
  3. Center for Hematologic Malignancies (1)
  4. Center for Pancreatic Cancer Research (1)
  5. Department of Medicine (1)
  6. Epidemiology and Biostatistics (1)

More Groups

People
  1. Andrew Zelenetz (1)
  2. Carol Portlock (1)
  3. Craig Moskowitz (1)
  4. Debra Sarasohn (1)
  5. Francis Sirotnak (1)
  6. Martin Fleisher (1)

More People

Years
  1. 2009 (1)
Publications
  1. Journal of Clinical Oncology (1)

Results (1)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase II-I-II study of two different doses and schedules of pralatrexate, a high-affinity substrate for the reduced folate carrier, in patients with relapsed or refractory lymphoma reveals marked activity in T-cell malignancies
    Journal Article

    O'Connor, O. A.; Horwitz, S.; Hamlin, P.; Portlock, C.; Moskowitz, C. H.; Sarasohn, D.; Neylon, E.; Mastrella, J.; Hamelers, R.; Macgregor-Cortelli, B.; more...
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save